Its involvement in three gene fusions (IGH-LHX2, ADAMTS13-LHX2, and AAK1-LHX2) has been described in chronic myelogenous leukemia, breast cancer, and uterine carcinosarcoma, respectively [34, 44]. Here, AAK1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.